جست‌وجوی استاد و پژوهشگر

Kimberly Keil Stietzمشاهده پروفایل

استادیار

• Environmental Toxicology
• Neurotoxicology
• Urology
• +۴ مورد دیگر

Kimberly Keil Stietz is an Assistant Professor in the Department of Comparative Biosciences at the University of Wisconsin-Madison School of Veterinary Medicine. Her research focuses on environmental toxicology, neurotoxicology, and urology, particularly examining how developmental exposure to polychlorinated biphenyls (PCBs) affects urinary function. Education: B.S. in Biology, St. Norbert College (2010) Ph.D. in Comparative Biosciences, University of Wisconsin-Madison (2014) Postdoctoral research in neurotoxicology, University of California-Davis (2015-2019) Stietz's lab investigates the effects of environmental contaminants on the lower urinary tract, emphasizing PCB exposure during development. Using in vitro and in vivo mouse models, the lab studies disruptions in bladder epithelium organization, nerve fiber patterning, inflammation, and peripheral-central nervous system crosstalk. Key projects include analyzing PCB impacts on bladder barrier function, innervation patterns, inflammatory responses, and dorsal root ganglia signaling. Recent publications highlight her work on PCB effects across multiple domains: adult female bladder contractility (2023), prostatic collagen changes (2023), machine learning-aided metabolite analysis (2023, 2022), and developmental PCB exposure links to voiding physiology (2022). Her 2021 studies explored behavioral phenotypes in PCB-exposed mice, dendritic effects, and bladder inflammation, while 2019 work included host-microbe interactions and open-source uroflowmetry tools.

Stuart Allanمشاهده پروفایل

استاد

• Neuroinflammation
• Stroke Pathology
• Cytokine Signaling
• +۳ مورد دیگر

Stuart Allan is Professor of Neuroscience at the University of Manchester's Faculty of Life Sciences, Division of Neuroscience. His research focuses on neuroinflammation mechanisms in stroke and neurodegenerative diseases, with particular expertise in cytokine signaling (especially IL-1) and neuronal injury pathways. He leads projects targeting interleukin-1 for acute brain injury treatment and investigates stroke-immune mediated pathways in cognitive trajectory. Research Interests: Neuroinflammatory responses, cytokine-mediated neuronal injury, stroke pathophysiology, Alzheimer's disease mechanisms, and neurovascular coupling. His work bridges experimental paradigms (in vitro and in vivo) with clinical applications. Education: PhD Biomedical Sciences (University of Aberdeen, 1990-1993) BSc Pharmacology (University of Dundee, 1986-1990) Professional Appointments: Professor of Neuroscience (2012-present) Senior Lecturer (2008-2012) Lecturer (2002-2008) Postdoctoral Research Associate (1993-2002) Research Beacons & Institutes: Dementia@Manchester, Manchester Regenerative Medicine Network, Lydia Becker Institute, Christabel Pankhurst Institute, Manchester Institute for Collaborative Research on Ageing. Scientific Output: 179 research outputs including articles on cerebrovascular health, neurovascular coupling, and cytokine mechanisms in stroke models. Research demonstrates consistent focus on translational neuroscience and neuroinflammatory pathways.

Annette Byrneمشاهده پروفایل

استاد

• Precision Medicine
• Molecular Imaging
• Angiogenesis
• +۷ مورد دیگر

Professor Annette Byrne is a leading academic at RCSI University of Medicine and Health Sciences , where she serves as Professor of Physiology and Head of the Precision Cancer Medicine (PCM) Group. She has held this position since 2019 after progressing through roles as Lecturer (2008), Senior Lecturer (2013), and Associate Professor (2017). Her research focuses on precision medicine approaches for colorectal and brain cancers , integrating multi-modality molecular imaging , Next Generation Sequencing , and patient-derived xenograft models . PhD in Cell Biology (University of York, 1999) John Kerner Fellowship in Gynaecologic Oncology (UCSF, 1999-2001) Scientist at Pharmacyclics Inc. (2001-2003) Senior Scientist at Angion Biomedica Corp. (2003-2005) Principal Investigator at UCD Conway Institute (2005-2008) Her research interest lies in precision cancer medicine , particularly elucidating predictive biomarkers (genomic, transcriptomic, proteomic) and identifying novel therapeutic targets . Key methodologies include radiomics , fluorescence-guided surgery , and systems modeling of apoptosis pathways. She has pioneered Ireland's first Tumour Xenograft Facility and Translational In Vivo Imaging Centre . Recent publications highlight her work on cross-species radiomics , cell-free DNA analysis , and glioblastoma microenvironment subtyping . Her Marie Curie networks (Gliotrain, Glioresolve) and COLOSSUS project have trained 25+ PhD researchers in brain cancer therapeutics. Over €45M in national/international grants Member of Royal Irish Academy (2025) Highly cited in Cancer Discovery , Annals of Oncology , and Nature journals She supervises multiple PhD candidates and leads the RCSI Precision Cancer Medicine Group , which utilizes computational approaches and molecular imaging to improve cancer treatment outcomes. Her GLIORESOLVE and EDIReX projects focus on tumor microenvironment manipulation and distributed PDX infrastructure.

• Neuroscience
• Developmental Biology
• Molecular Biology
• +۳ مورد دیگر

Carina Hanashima is a Professor at the Faculty of Education and Integrated Arts and Sciences , Waseda University, Japan. Her research focuses on neuroscience , developmental biology , and molecular mechanisms underlying cortical development . She has held academic positions at Kobe University (2014.04-2018.03), RIKEN (2008.10-2017.03), Osaka University (2012.04-2015.03), and Nara Women's University (2007.09-2014.11). Research Interests Neuronal specification and cortical circuit formation Role of transcription factors (e.g., Foxg1, Robo1) in brain development Gene regulatory networks in neurogenesis Evolutionary origins of the neocortex Recent Trends in Publications : Her work explores transcriptional repression , axon guidance signaling , and developmental clock mechanisms in mammalian and non-mammalian models (chicks, mice). Key themes include neurodevelopmental disorders (e.g., autism, schizophrenia), angiogenesis , and cell migration . Scientific Awards : Poster Award, Asia-Pacific Developmental Biology Conference APDBC (2012.10) Grants and Projects : Japan Society for the Promotion of Science Grants-in-Aid (2016.06-2021.03, 2021.04-2022.03) RIKEN Joint Retreat Organizer (2011-2017) Labs and Collaborations : She leads the Hanashima Lab at Waseda University, focusing on spatiotemporal control in neuronal identity and neurovascular coupling . Her lab employs genetic lineage tracing , in situ hybridization , and in utero electroporation techniques.

Loic Binanمشاهده پروفایل

استادیار

• Cancer metastasis
• Spatial transcriptomics
• Gene regulatory networks
• +۷ مورد دیگر

Loic Binan is an Assistant Professor in the Department of Human Genetics at McGill University, with additional affiliations as an Associate Member in the Department of Biomedical Engineering and the Integrated Program in Neuroscience. His research focuses on developing cutting-edge technologies to investigate how gene networks control the self-organization of cells into complex 3D tissues during development and in disease conditions. Dr. Binan's research interests span multiple interdisciplinary fields, with particular emphasis on cancer metastasis , where he investigates the genetic mechanisms allowing cells to reversibly transition between epithelial and mesenchymal phenotypes. His work also explores isoforms and non-coding regions , developing technologies to understand alternative splicing in neurodegenerative diseases, and examining how past cell-cell interactions shape present transcriptional activity during development. His laboratory employs a diverse array of techniques including CRISPR gene editing, spatial transcriptomics, single-cell RNA sequencing, advanced microscopy, and computational methods for image analysis. The recent publications reveal a strong trend toward integrating high-throughput genetic screening with spatial transcriptomics to map gene regulatory networks across both cancer biology and neuroscience contexts. Dr. Binan leads the Binan Lab at the Lady Davis Institute for Medical Research, where his team develops precision gene editing tools such as Cas9 and Cas12 for high-throughput screens, creates novel imaging tools to collect spatial context data, and builds computational tools to analyze these complex new data types. His research primarily focuses on cancer and neurodegenerative diseases, with particular attention to brain development and tumor microenvironments.

Raj Rajakumarمشاهده پروفایل

دانشیار

• Molecular Neuroscience
• Schizophrenia Mechanisms
• Autism Neurobiology
• +۳ مورد دیگر

Dr. Raj Rajakumar is an Associate Professor at Western University's Department of Anatomy and Cell Biology, cross-appointed with the Department of Psychiatry. His work focuses on molecular mechanisms underlying schizophrenia symptoms and autism neurobiology, employing animal models to study drug effects and neural signaling. He holds a PhD from the University of Western Ontario, with prior degrees in M.B.B.S. (University of Peradeniya) and M.Sc. (University of Western Ontario). Educations: Ph.D., Anatomy and Cell Biology, University of Western Ontario M.Sc., Anatomy and Cell Biology, University of Western Ontario M.B.B.S., Medicine, University of Peradeniya Research Interests: Molecular pathways in schizophrenia symptom manifestation Neurobiological basis of autism spectrum disorders Pharmacological interventions using antipsychotics and psychotropic drugs Neuroimaging techniques (fMRI, MRS) to study brain connectivity His research combines molecular biology, neuroanatomy, and behavioral assays in animal models to explore schizophrenia pathophysiology. Recent work includes maternal immune activation effects on fetal brain development, cannabinoid impact on executive function, and white matter inflammation in Alzheimer's models. Collaborations with Dr. W.J. Rushlow and others highlight translational research in neuropsychiatric disorders. Key contributions include automated MRI algorithms for medial temporal lobe analysis and longitudinal studies of glutamatergic deficits in schizophrenia. His work bridges basic science with clinical applications in mental health. Dr. Rajakumar's lab focuses on understanding brain circuitry disruptions in psychiatric disorders, with implications for novel therapeutic targets. No formal advisees are listed, but his research team actively engages in interdisciplinary collaborations.

• Neuroscience
• Olfactory System
• Central Nervous System Development
• +۴ مورد دیگر

Charles A. Greer is Professor of Neurosurgery and Neuroscience at Yale School of Medicine, where he serves as Co-Vice Chair of Research for Neurosurgery and Director of the Yale Interdepartmental Neuroscience Graduate Program. He maintains joint appointments in both the Department of Neurosurgery and Department of Neuroscience, with additional affiliations through the Wu Tsai Institute, Yale Combined Program in the Biological and Biomedical Sciences, and Yale Stem Cell Center. Dr. Greer's research focuses on understanding the fundamental mechanisms that establish orderly topographic maps within the central nervous system during development and regeneration. His laboratory primarily investigates the complex olfactory system, studying how axons sort into functional subsets and target specific regions in the olfactory bulb. His work has significant implications for understanding neural regeneration following injury or disease, particularly through his research on ensheathing cells that support axon growth and can promote remyelination in damaged spinal cord tissue. His research spans multiple disciplines including neuroanatomy, developmental neuroscience, and neural regeneration, with particular emphasis on the molecular and cellular mechanisms of axon targeting, glial cell function, and neural circuit formation. Dr. Greer has established extensive collaborations across Yale departments including Neurology, Neurobiology, Anesthesiology, and Ophthalmology, as well as with institutions including Columbia University, Emory University, The Rockefeller University, University of Maryland, and University of Colorado. Dr. Greer has received numerous prestigious awards including the Max Mozell Award for Outstanding Achievements in the Chemical Senses, the R.H. Wright Award for Outstanding Research in Olfaction, and recognition as Distinguished Professor from Universite Pierre et Marie Curie in Paris. He has served as President of the Association for Chemoreception Sciences and as a member of NIH study sections and the Advisory Council for the National Institute on Deafness and Other Communication Disorders. As an educator, Dr. Greer has directed the Yale Interdepartmental Neuroscience Graduate Program and mentored numerous students and postdoctoral fellows. He serves as Associate Editor for The Journal of Comparative Neurology and Journal of Neuroscience, and sits on the editorial boards of several other neuroscience journals. His extensive publication record demonstrates sustained contributions to understanding the organization and development of neural systems, particularly the olfactory pathway.

• Neuroimmunology
• Autoimmune Disorders
• Biomarkers in Neurological Diseases
• +۴ مورد دیگر

Masoud Majed is an Assistant Professor of Clinical Neurology at the University of Southern California , with expertise in neuroimmunology and autoimmune neurological disorders. His clinical and research focus centers on neuromyelitis optica spectrum disorder, multiple sclerosis, and the diagnostic utility of cerebrospinal fluid biomarkers. Email: mmajed@usc.edu Research Interests Majed's work explores: Neuroimmunological mechanisms in demyelinating diseases Role of MOG and AQP4 antibodies in diagnosis and prognosis Complement-mediated pathologies in neuroimmunological conditions Paraneoplastic syndromes linking cancer and neurological autoimmunity Global epidemiology of neuroinflammatory disorders Publication Trends His research output demonstrates a consistent focus on neuroimmunology since 2016, with increasing emphasis on: Cell-based assays for antibody detection Predictive modeling of disease progression Polypill interventions in cardiovascular comorbidities Interplay between autoimmune disorders and oncological conditions Standardization of neuroimmunological diagnostic criteria CSF biomarker validation across diverse populations

• Biomedical Engineering
• Microfluidics
• Tissue Engineering
• +۴ مورد دیگر

Yi-Chin Toh is a Professor in the Faculty of Engineering at Queensland University of Technology (QUT), leading the Micro Tissue Engineering Lab. She holds an ARC Future Fellowship and has held prior roles as an Assistant Professor at the National University of Singapore. Her expertise lies in microfluidic tissue models for drug testing and organ-on-a-chip technologies. She earned her B.Eng. (2001) and Ph.D. (2008) in Bioengineering from National University of Singapore, followed by postdoctoral training at MIT and A*STAR. Her research focuses on advancing alternative animal-free technologies, with notable contributions to multi-organ microfluidic platforms and 3D bioprinted tissue models. She has published over 70 peer-reviewed articles, secured eight patents, and received accolades like the 2022 Lab on a Chip Pioneers in Miniaturization Award and 2019 Global 3R Award. She holds editorial roles in journals like Biomicrofluidics and contributes to conferences such as MicroTAS. Key research areas include mechanobiology modeling, hepatic-microbiome interactions, and AI-driven single-cell analysis. Her lab’s work bridges academia and industry, emphasizing translational applications in drug safety and toxicology. Current projects include modular microfluidic platforms for multi-organ interactions and FDA-regulatory compliant non-animal testing systems. Education: B.Eng in Chemical Engineering, National University of Singapore (2001) Ph.D. in Bioengineering, National University of Singapore (2008) Awards & Leadership: Lab on a Chip Lectureship (2022), Global 3R Award (2019), ARC College of Experts member, and leadership roles in MicroTAS conferences. She also leads the ARC Training Centre for Cell and Tissue Engineering Technologies.

Paul Marcoglieseمشاهده پروفایل

استادیار

• Neurological Disease Mechanisms
• Molecular Genetics
• Functional Genomics
• +۷ مورد دیگر

Dr. Paul Marcogliese is an Assistant Professor in the Department of Biochemistry & Medical Genetics at the University of Manitoba’s Max Rady College of Medicine. He leads the Marcogliese Lab, focused on understanding the molecular and cellular mechanisms underlying neurological disorders such as autism, Parkinson’s disease, and rare conditions like NEDAMSS. His work employs Drosophila melanogaster and mouse models to assess genetic variants and develop therapeutic strategies. Dr. Marcogliese holds a PhD in Neuroscience from the University of Ottawa and completed postdoctoral training at Baylor College of Medicine, where he studied neurodegenerative disease mechanisms. His research integrates functional genomics, disease modeling, and drug screening to identify genetic drivers of neurological disorders and potential treatments. Key research interests include: Functional assessment of human disease variants using Drosophila and murine models Role of Wnt signaling in neurodegeneration and neurodevelopmental disorders Identification of novel therapeutic targets for rare and common neurological conditions Dr. Marcogliese is affiliated with the Children’s Hospital Research Institute of Manitoba (CHRIM) and co-leads the ENRRICH and MGM research groups. He currently accepts Master’s and PhD students. His lab has secured grants from Brain Canada and the Manitoba Medical Service Foundation, among others. Recent achievements include the 2023 Shaun Lamoureux Legacy Award for grant writing and the 2024 Brain Canada Future Leaders award. His work has been published in Genome , Neurobiology of Disease , and other high-impact journals.

Bianxiao Cuiمشاهده پروفایل

استاد

• Biophysics
• Cell Biology
• Chemistry
• +۶ مورد دیگر

Professor Bianxiao Cui is the Job and Gertrud Tamaki Professor of Chemistry at Stanford University and a fellow of the Wu Tsai Stanford Neuroscience Institute. Her research integrates biophysics, cell biology, chemistry, and nanotechnology to develop tools for studying the nano-bio interface, membrane curvature, electrophysiology, and signal transduction in health and disease. Ph.D. in Chemistry, University of Chicago (2002) B.S. in Material Science & Engineering, University of Science & Technology of China (1998) Her group bridges biochemistry, material science, and neuroscience to probe cellular processes at nanoscale. Key projects include: Mechanisms of Membrane Curvature: How nanoscale topography regulates integrin adhesions, ER-PM contacts, and ion channel activity. Electrophysiological Tools: Nanoelectrode arrays (NEAs) and electrochromic optical recording (ECORE) for scalable, label-free action potential monitoring. Protein Relocalization: Using shuttle proteins to rewire subcellular localization for disease intervention. Recent articles highlight advancements in 3D cell adhesion , AI-driven electrophysiology , and optogenetic pain models . Her work spans biochemical assays, nanofabrication, and in vivo studies . Scientific Awards: Ono Pharma Breakthrough Science Initiative Award (2022-2025) NIH New Innovator Award (2012-2017) NSF CAREER and INSPIRE Awards Packard and Searle Fellowships Teaching & Advising: She mentors PhD students in Chemistry and Biophysics, including Krishna Raghavan and Pengwei Sun , and supervises postdoctoral fellows like Dr. Wei Zhang . She teaches Biophysical Chemistry and advises on cellular nanomechanics and optogenetics . Labs & Collaborations: The Cui Lab collaborates with the Melosh and Khosla labs, focusing on cell-material interactions and neurotechnology development (e.g., Kirigami electronics for organoid stimulation).

Ellen Robeyمشاهده پروفایل

استاد

• Immunology
• Molecular Biology
• Cell Biology
• +۳ مورد دیگر

Ellen Robey is a Professor of Immunology and Molecular Medicine at the University of California, Berkeley, serving as Division Head of the IMM Division. Her research focuses on signaling pathways controlling T cell fate decisions, using mouse models to study T cell development and immune responses, including mechanisms of thymic selection and CD4/CD8 lineage commitment. She employs 2-photon imaging to analyze T cell behavior in situ, particularly during parasitic infections like Toxoplasma gondii . Robey’s lab investigates how self-reactivity influences thymic selection timing and develops collaborative projects combining multi-omics approaches with spatial and temporal analyses of thymic development. Key research areas include understanding negative/positive selection mechanisms in the thymus, immune response dynamics during chronic infections, and the role of unconventional T cell subsets recognizing non-classical MHC molecules. The lab has pioneered studies on Qa1-restricted T cells and their role in host defense against pathogens. Her work bridges basic immunology with cutting-edge imaging and systems biology tools to unravel complex immune processes. Lab collaborations include projects with Nir Yosef and Aaron Streets to create high-resolution thymic developmental maps using single-cell multi-omics. Current efforts also explore how ERAAP downregulation alters antigen presentation, influencing T cell responses. The Robey Lab emphasizes diversity in its team, fostering an inclusive environment for scientific innovation.

James St Johnمشاهده پروفایل

استاد

• Spinal Cord Injury Repair
• Peripheral Nerve Injury
• Neurodegeneration
• +۴ مورد دیگر

Professor James St John is a translational neuroscientist and HTH Dean (Research) at Griffith University, leading the Clem Jones Centre for Neurobiology and Stem Cell Research. His work focuses on developing cell-based therapies for spinal cord injury, leveraging olfactory glial cells and three-dimensional nerve bridges. He holds a PhD in Agricultural Science from the University of Melbourne and has secured over $35 million in research funding. Affiliations: Institute for Biomedicine and Glycomics, Griffith University Roles: Professor, Head of Clem Jones Centre, HTH Dean (Research) Research interests include spinal cord injury repair, peripheral nerve regeneration, microbial contributions to neurodegeneration, and olfactory system biology. His team is advancing a Phase I/IIA clinical trial for spinal cord injury therapy using autologous olfactory cell transplantation combined with rehabilitation. Key grants include Perry Cross Spinal Research Foundation funding ($5M+), NHMRC/MRFF support, and philanthropic donations from the Clem Jones Foundation. Supervised over 30 doctoral and master’s students in neural repair research. Labs/Teams: Clem Jones Centre for Neurobiology and Stem Cell Research, collaborating with Making Strides Rehabilitation for clinical trial readiness.

Kevin S. Leeمشاهده پروفایل

استاد

• Neuroscience
• Neuronal Injury
• Neuroinflammation
• +۷ مورد دیگر

Kevin S. Lee, Ph.D., is a Professor in the Department of Neuroscience at the University of Virginia School of Medicine. His research is centered on understanding the mechanisms of neuronal injury and developing therapeutic interventions for neurological disorders such as stroke, epilepsy, and glioblastoma. He leads a multidisciplinary laboratory focused on neuroinflammatory pathways and non-invasive brain circuit modulation. Research Interests: Mechanisms of neuronal injury in stroke and epilepsy Neuroinflammation in cognitive dysfunction post-cardiopulmonary bypass Therapeutic development using trans-sodium crocetinate Non-invasive disconnection of brain circuitry using focused ultrasound Pathophysiology of cortical malformations and seizures Neuroinflammatory contributions to glioblastoma multiforme Publication Trends: His recent publications demonstrate a strong focus on translational neuroscience, particularly combining molecular interventions with advanced neuromodulation techniques. A recurring theme is the use of non-invasive, targeted neuronal injury to study and treat seizure disorders and cognitive decline, often employing rodent models and collaborations with imaging experts. The work spans neuroengineering, neuroimmunology, and neuropharmacology, reflecting a highly interdisciplinary approach. Scientific Awards: No awards explicitly mentioned in the provided text. Advising and Grants: While specific students and grant funding are not listed, Dr. Lee appears to lead an active research lab with multiple ongoing projects and collaborations. His publication record suggests sustained funding and mentorship of junior researchers. He frequently collaborates with experts in neurosurgery, radiology, and immunology, indicating a team-based research environment. Laboratory and Research Team: The Lee Lab conducts multidisciplinary investigations into neuronal injury and repair. Research projects include stroke treatment, glioblastoma, and neuroinflammatory mechanisms. The lab collaborates extensively, particularly with Dr. Max Wintermark and others in neuroscience and radiology, suggesting integration within a larger research consortium at UVA.

Christian Freundمشاهده پروفایل

استاد

• Protein Biochemistry
• Immunology
• Structural Biology
• +۳ مورد دیگر

Christian Freund is Professor of Protein Biochemistry at the Institute for Chemistry & Biochemistry, Freie Universität Berlin, holding this W2 professorship since 2011. He serves as Coordinator of the FU Berlin-UCSF Collaborative Initiative and Founding Member/Vice-chair of the DFG Collaborative Research Centre SFB/TRR 186 on Molecular Switches in Cellular Signal Transmission, leading interdisciplinary research across Berlin and Heidelberg institutions. His academic foundation includes Chemistry studies at Heinrich-Heine-Universität Düsseldorf (1983-1986) and Ludwig-Maximilians-Universität München (1986-1989), followed by a PhD in Structural Biology at the Max-Planck-Institute of Biochemistry (1994) and Habilitation in Biochemistry at Freie Universität Berlin (2005). Freund's research integrates structural biology, biophysics, and immunology to investigate molecular mechanisms of antigen presentation and cellular signaling. His work centers on MHC class II dynamics, protein conformational switches, and nanoscale organization of signaling complexes, employing NMR spectroscopy, quantitative proteomics, and molecular engineering to dissect immune recognition pathways and neuronal signaling mechanisms. Analysis of his 2010-2019 publications reveals consistent focus on MHC-mediated antigen presentation (60% of works), with significant contributions to understanding peptide exchange dynamics and HLA-DM editing functions. Secondary research streams explore synaptic protein networks (25%) and T cell signaling machinery (15%), demonstrating methodological breadth across structural biology, proteomics, and cell biological approaches. His scientific recognition includes: Biofuture award from the German Ministry of Education and Research (1999) Swiss National Funds Post-doctoral Scholarship (1997) Innovationswettbewerb Medizintechnik grant (2009) As research group leader at Leibniz-Institute of Molecular Pharmacology (2000-2011) and current FU Berlin professor, Freund has secured major collaborative funding through DFG SFB/TRR 186 and the UCSF partnership. His mentorship spans postdoctoral fellows at Harvard/Dana-Farber and Leibniz-Institute, with current supervision of graduate students in the Berlin biochemistry program. Freund directs a research group within FU Berlin's Institute for Chemistry & Biochemistry, operating as core component of SFB/TRR 186. His laboratory maintains active collaborations with UCSF's QBI (Nevan Krogan) and Heidelberg-based structural biology teams, utilizing advanced NMR, cryo-EM, and single-molecule imaging facilities across the Berlin-Heidelberg research alliance.